Home
News
Screeners
Insights
Chandra Bhagat Pharma
49.
90
0.00
(0.00%)
Market Cap
₹37.70 Cr
PE Ratio
12.35
Industry
Healthcare
Buy
Sell
Company Performance:
1D
0.00%
1M
+50.94%
6M
+24.44%
1Y
-15.42%
5Y
-45.76%
View Company Insights
Latest news about Chandra Bhagat Pharma
Chandra Bhagat Pharma seeks approval for ₹29.04 cr warrant issue
Aug 06, 2026
Chandra Bhagat Pharma Limited is holding its 23rd AGM on September 1, 2026, to approve a ₹29.04 crore convertible warrant issue and an increase in authorized share capital to ₹15 crore. The company reported a PAT of ₹304.61 lakh for FY26, driven by revenue growth to ₹11,627.17 lakh. Proceeds from the warrant issue will fund working capital and expansion into vaccine formulations.
Chandra Bhagat Pharma plans fund raise via preferential allotment
Jul 30, 2026
Chandra Bhagat Pharma FY26 net profit rises 255% to ₹304.61 lakh
May 25, 2026
Chandra Bhagat Pharma Limited Opens New International Office in Dubai, UAE
Apr 01, 2026
Chandra Bhagat Pharma Files Corporate Governance Non-Applicability Certificate for Q3 FY26
Jan 21, 2026
More news about Chandra Bhagat Pharma
13
Nov 25
Chandra Bhagat Pharma Reports Half-Year Financial Results for September 2025
Chandra Bhagat Pharma Limited announced its unaudited financial results for the half year ended September 30, 2025. The company reported revenue from operations of ₹2,354.60 lakhs and a profit after tax of ₹44.91 lakhs. The results were approved by the Board of Directors and reviewed by A Y & Company, Chartered Accountants. The company's trading window will reopen 48 hours after the announcement of the financial statement, in compliance with SEBI regulations on insider trading.
Chandra Bhagat Pharma
49.
90
0.0
(0.0%)
1 Year Returns:
-15.42%
Industry Peers
Sun Pharmaceutical
1,893.60
(-
0.
34
%)
Divis Laboratories
8,554.00
(-
0.
07
%)
Torrent Pharmaceuticals
4,990.50
(-
0.
45
%)
Cipla
1,431.00
(+
0.
63
%)
Zydus Life Science
1,115.90
(+
1.
03
%)
Lupin
2,218.00
(-
0.
31
%)
Mankind Pharma
2,401.10
(+
0.
30
%)
Laurus Labs
1,824.40
(+
1.
25
%)
Dr Reddys Laboratories
1,173.30
(+
0.
28
%)
Aurobindo Pharma
1,627.00
(+
0.
15
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar